{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T09:26:31Z","timestamp":1784366791102,"version":"3.55.0"},"reference-count":21,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2013,4,26]],"date-time":"2013-04-26T00:00:00Z","timestamp":1366934400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0061637","type":"journal-article","created":{"date-parts":[[2013,4,26]],"date-time":"2013-04-26T21:02:42Z","timestamp":1367010162000},"page":"e61637","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":74,"title":["Improved Clinical Outcomes of High Risk \u03b2 Thalassemia Major Patients Undergoing a HLA Matched Related Allogeneic Stem Cell Transplant with a Treosulfan Based Conditioning Regimen and Peripheral Blood Stem Cell Grafts"],"prefix":"10.1371","volume":"8","author":[{"given":"Vikram","family":"Mathews","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biju","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Auro","family":"Viswabandya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aby","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayaz","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijeet","family":"Ganapule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunice","family":"Sindhuvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavitha M.","family":"Lakshmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alok","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,4,26]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0140-6736(82)90319-1","article-title":"Marrow transplantation for thalassaemia","volume":"2","author":"ED Thomas","year":"1982","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0140-6736(85)91784-2","article-title":"Marrow transplantation for thalassaemia following busulphan and cyclophosphamide","volume":"1","author":"G Lucarelli","year":"1985","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM199002153220701","article-title":"Bone marrow transplantation in patients with thalassemia","volume":"322","author":"G Lucarelli","year":"1990","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1182\/blood.V80.6.1603.1603","article-title":"Bone marrow transplantation in adult thalassemia","volume":"80","author":"G Lucarelli","year":"1992","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.bbmt.2007.05.004","article-title":"A new stratification strategy that identifies a subset of class III patients with an adverse prognosis among children with beta thalassemia major undergoing a matched related allogeneic stem cell transplantation","volume":"13","author":"V Mathews","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1182\/blood-2010-09-306829","article-title":"HLA-matched sibling bone marrow transplantation for beta-thalassemia major","volume":"117","author":"M Sabloff","year":"2010","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.bbmt.2009.11.024","article-title":"Unpredictability of intravenous busulfan pharmacokinetics in children undergoing hematopoietic stem cell transplantation for advanced beta thalassemia: limited toxicity with a dose-adjustment policy","volume":"16","author":"R Chiesa","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1046\/j.1365-2141.2003.04065.x","article-title":"Bone marrow transplantation for beta-thalassaemia major: the UK experience in two paediatric centres","volume":"120","author":"SE Lawson","year":"2003","journal-title":"Br J Haematol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1182\/blood-2003-08-2800","article-title":"New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years","volume":"104","author":"P Sodani","year":"2004","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1182\/blood.V87.5.2082.2082","article-title":"Marrow transplantation for patients with thalassemia: results in class 3 patients","volume":"87","author":"G Lucarelli","year":"1996","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1365-2141.2008.07385.x","article-title":"Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major","volume":"143","author":"ME Bernardo","year":"2008","journal-title":"Br J Haematol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/bmt.2011.88","article-title":"Treosulfan-based conditioning before hematopoietic SCT: more than a BU look-alike","volume":"47","author":"I Danylesko","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1182\/blood-2003-11-3778","article-title":"Glutathione S-transferase M1 polymorphism: a risk factor for hepatic venoocclusive disease in bone marrow transplantation","volume":"104","author":"A Srivastava","year":"2004","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/sj.bmt.1705151","article-title":"Randomized trial of two different conditioning regimens for bone marrow transplantation in thalassemia\u2013the role of busulfan pharmacokinetics in determining outcome","volume":"36","author":"M Chandy","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.bbmt.2009.01.016","article-title":"Cellular immune reconstitution and its impact on clinical outcome in children with beta thalassemia major undergoing a matched related myeloablative allogeneic bone marrow transplant","volume":"15","author":"R Rajasekar","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1182\/blood-2012-03-417998","article-title":"A novel conditioning regimen improves outcomes in beta-thalassemia major patients using unrelated donor peripheral blood stem cell transplantation","volume":"120","author":"C Li","year":"2012","journal-title":"Blood"},{"key":"ref17","article-title":"Allogeneic hematopoietic stem cell transplantation in thalassemia major: results of a reduced-toxicity conditioning regimen based on the use of treosulfan","author":"ME Bernardo","year":"2012","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/sj.bmt.1705317","article-title":"Developing an algorithm of informative markers for evaluation of chimerism after allogeneic bone marrow transplantation","volume":"37","author":"S Sellathamby","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors","volume":"18","author":"H Glucksberg","year":"1974","journal-title":"Transplantation"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","article-title":"Venoocclusive disease of the liver following bone marrow transplantation","volume":"44","author":"RJ Jones","year":"1987","journal-title":"Transplantation"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1054\/blre.2002.0192","article-title":"The cure of thalassemia by bone marrow transplantation","volume":"16","author":"G Lucarelli","year":"2002","journal-title":"Blood Rev"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0061637","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T14:52:55Z","timestamp":1715266375000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0061637"}},"subtitle":[],"editor":[{"given":"Wilbur","family":"Lam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,4,26]]},"references-count":21,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0061637","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,26]]}}}